Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01881178 · ClinicalTrials.gov registry record · NA
The Effect of a Nutritional Supplement Product Containing Cactus Fruit Juice (Nopalea) on C-Reactive Protein
A NA study of Inflammation, sponsored by Mark Mattie.
- Completed
- Registry status
- NA
- Development phase
- 287
- Enrollment target
- 1
- Study location
NCT01881178: Completed NA study of Inflammation, sponsored by Mark Mattie.
NCT01881178 is a NA study of Inflammation that has completed, run by Mark Mattie. The registered enrollment target is 287 participants, roughly in line with the 286-participant average among 132 other Inflammation trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01881178, a NA study of Inflammation, has completed, sponsored by Mark Mattie.
- COMPLETED
- Registry status
- NA
- Development phase
- 287 participants
- Enrollment target
- 1
- Study location
Study Summary
This study has been developed to investigate the anti-inflammatory effects of a commercial product (Nopalea) containing Prickly Pear Cactus Fruit Juice in healthy adults. The research method employs a double blind, placebo controlled, and time-series (repeat measures) design with high-sensitivity C-Reactive Protein (HS-CRP) serving as a marker for inflammation - testing for levels of CRP at time points: baseline (pre-test), 8 weeks (60 days) and 12 weeks (90 days). The final time point (i.e., 12 weeks) will serve as the post-test. It is expected that baseline CRP levels in healthy participants will decline.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT NOPALEA
Study Locations (1)
Arizona
- Trivita Wellness Center - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 287 participants |
| Start Date | 2013-05 |
| Est. Completion | 2014-03 |
| Phase | NA |
What the finished NCT01881178 record still lists
NCT01881178 is an interventional study that assigns participants to a tested intervention. The registered 287 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 286-participant average among 132 other Inflammation trials with a reported enrollment target.
The record links to 1 condition, with Inflammation appearing as the primary indexed condition, and to 1 intervention - of which NOPALEA is the first listed.
NCT01881178 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT01881178 about?
NCT01881178 is a clinical study titled "The Effect of a Nutritional Supplement Product Containing Cactus Fruit Juice (Nopalea) on C-Reactive Protein". This study has been developed to investigate the anti-inflammatory effects of a commercial product (Nopalea) containing Prickly Pear Cactus Fruit Juice in healthy adults. The research method employs a double blind, placebo controlled, and time-series (repeat measures) design with high-sensitivity C-...
What is the current status of trial NCT01881178?
This trial is currently completed. It is a NA study. The enrollment target is 287 participants. The study started on 2013-05. Estimated completion is 2014-03.
What conditions does trial NCT01881178 study?
This clinical trial studies the following conditions: Inflammation.
What interventions are being tested in trial NCT01881178?
The interventions under investigation include: NOPALEA (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01881178?
This trial is sponsored by Mark Mattie, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01881178 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01881178's enrollment target sits among peer trials
287 20th of 132 higher than 113 of 132 other Inflammation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inflammation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
RECRUITING · NA
-
Evaluating Whether Hyperbaric Oxygen Therapy Can Improve VO₂-Max and Reduce Inflammation Markers in Healthy Adults Ages 30-60.
RECRUITING · NA
-
Impact of NMES and HPRO on Recovery After SAH- Pilot Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03094429 · 287 participants · Phase 2
An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults
- NCT06385080 · 287 participants · Phase 1
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
- NCT06919224 · 287 participants · NA
Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
- NCT02098265 · 288 participants · NA
A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia